DNACF(DNACF)
DNACF
No analyst ratings available
No analyst price targets available for DNACF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $150.73B | $154.46B | $154.17B | $154.74B |
| Low | $143.81B | $146.71B | $146.76B | $147.30B |
| High | $156.83B | $165.20B | $162.68B | $163.29B |
| EBITDA Avg | $55.87B | $33.01B | $32.30B | $35.09B |
| Low | $52.96B | $31.56B | $30.91B | $33.54B |
| High | $59.20B | $34.68B | $33.89B | $36.87B |
| EBIT Avg | $48.40B | $25.17B | $24.17B | $26.72B |
| Low | $45.49B | $23.72B | $22.78B | $25.17B |
| High | $51.73B | $26.84B | $25.77B | $28.50B |
| Net Income Avg | $38.58B | $19.30B | $18.47B | $20.59B |
| Low | $36.17B | $18.09B | $17.31B | $19.30B |
| High | $41.35B | $20.68B | $19.79B | $22.06B |
| EPS Avg | $346.24 | $173.20 | $165.72 | $184.75 |
| Low | $324.59 | $162.37 | $155.36 | $173.20 |
| High | $371.08 | $185.63 | $177.61 | $198.01 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $42.17B | $31.37B | $34.12B | $56.32B | $58.90B | $56.30B | $54.00B |
| Low | $41.36B | $30.33B | $33.27B | $54.91B | $57.42B | $54.89B | $52.64B |
| High | $42.99B | $32.40B | $34.98B | $57.74B | $60.38B | $57.72B | $55.36B |
| EBITDA Avg | $11.01B | $2.17B | $4.98B | — | — | — | — |
| Low | $10.75B | $2.14B | $4.92B | — | — | — | — |
| High | $11.27B | $2.20B | $5.05B | — | — | — | — |
| EBIT Avg | $9.08B | $239M | $3.05B | — | — | — | — |
| Low | $8.82B | $210M | $2.99B | — | — | — | — |
| High | $9.34B | $268M | $3.11B | — | — | — | — |
| Net Income Avg | $6.61B | $-884M | $1.60B | — | — | — | — |
| Low | $6.39B | $-913M | $1.55B | — | — | — | — |
| High | $6.82B | $-855M | $1.65B | — | — | — | — |
| EPS Avg | $65.66 | $-8.78 | $15.89 | — | — | — | — |
| Low | $63.52 | $-9.07 | $15.37 | — | — | — | — |
| High | $67.81 | $-8.50 | $16.41 | — | — | — | — |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / — | 1 / — | 1 / — | 1 / — |